5-ARI recalled due to possible mislabeling

April 7, 2011

Greenstone LLC has announced that it is voluntarily conducting a recall of medicines with lot number FI0510058-A on the label, including the 5-alpha-reductase inhibitor finasteride, 5 mg tablets (90-count).

Greenstone LLC has announced that it is voluntarily conducting a recall of medicines with lot number FI0510058-A on the label, including the 5-alpha-reductase inhibitor finasteride, 5 mg tablets (90-count).

The recall also includes citalopram (Celexa), 10 mg (100-count), which is used to treat depression.

The recall is due to the possibility that a third-party manufacturer has placed incorrect labels on the bottles; specifically, bottles that are labeled as citalopram lot number FI0510058-A may contain finasteride, which is indicated for treatment of BPH. This is the only lot number being recalled, and no other lots or markets are believed to be impacted.

Bottles of either citalopram or finasteride with lot number FI0510058-A should be returned to the pharmacist, according to a statement from Greenstone.